Astria Therapeutics Inc | ARS: Annual Report to Security Holders
Astria Therapeutics Inc | DEFA14A: Others
Astria Therapeutics Inc | DEF 14A: Definitive information statements
Astria Therapeutics Inc | 4: Statement of changes in beneficial ownership of securities-Officer Milne Jill C.
Astria Therapeutics Inc | 4: Statement of changes in beneficial ownership of securities-Officer Matthews Andrea
Astria Therapeutics Inc | 4: Statement of changes in beneficial ownership of securities-Officer Komjathy Andrew
Astria Therapeutics Inc | 4: Statement of changes in beneficial ownership of securities-Officer Harshbarger Benjamin
Astria Therapeutics Inc | 4: Statement of changes in beneficial ownership of securities-Officer Clauser Noah
Astria Therapeutics Inc | 4: Statement of changes in beneficial ownership of securities-Officer Morabito Christopher
Astria Therapeutics Inc | 10-K: FY2024 Annual Report
Astria Therapeutics Inc | 8-K: Astria Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update
Astria Therapeutics Inc | SCHEDULE 13G/A: Others
Astria Therapeutics Inc | SCHEDULE 13G/A: Others
Astria Therapeutics Inc | SCHEDULE 13G/A: Others
Astria Therapeutics Inc | SCHEDULE 13G/A: Others
Astria Therapeutics Inc | 8-K: Current report
Astria Therapeutics Inc | SCHEDULE 13G: Others
Astria Therapeutics Inc | 8-K: Current report
Astria Therapeutics Inc | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners III, L.P.(6.1%),VHCP Co-Investment Holdings III, LLC(6.1%), etc.
Astria Therapeutics Inc | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(9.0%),Peter Kolchinsky(9.0%), etc.